Life sciences news
-
UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis
Friday December 10th 2021
Read more
-
Early detection of Omicron facilitated with Emweb's Genome Detective
Friday December 10th 2021
Read more
-
Biocartis’ Idylla™ SARS-CoV-2 testing successfully detects Omicron variant
Thursday December 9th 2021
Read more
-
MRM Health announces first patient dosed with next generation live microbiome consortia therapeutic MH002 in Phase 1b/2a study in patients with Ulcerative Colitis
Wednesday December 8th 2021
Read more
-
Spectacular results with Japanese encephalitis vaccine of ViroVet
Wednesday December 8th 2021
Read more
-
Sequana Medical announces the completion of patient enrolment in POSEIDON, the North American pivotal alfapump® study
Tuesday December 7th 2021
Read more
-
Sequana Medical announces positive interim results of SAHARA DESERT, the alfapump DSR® study in heart failure patients with persistent congestion
Tuesday December 7th 2021
Read more
-
New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster
Monday December 6th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Celyad Oncology announces $32.5 million private placement with Fortress Investment Group
Monday December 6th 2021
Read more
-
SeptiCyte® RAPID receives 510(k) clearance by US FDA
Wednesday December 1st 2021
Read more
-
QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences
Wednesday December 1st 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
